111 filings
Page 4 of 6
8-K
vhn7avomdp9fu2qu
9 Jul 21
Entry into a Material Definitive Agreement
8:00am
8-K
q3enyk9 i8q9buo2
6 Jul 21
The Phase 3 ONWARD™ Trial Meets its Screening Target and Nears Enrollment Completion
10:35am
8-K
m30z87g qge
25 Jun 21
Adial Pharmaceuticals Provides Regulatory and Development Update
12:00am
8-K
daeff30j
22 Jun 21
Adial Pharmaceuticals Plans to Enter Genetic Testing Market Following Allowance of U.S. Patent for Genetic Diagnostic Test
9:58pm
8-K
e2wkl 0zf
4 Jun 21
Adial Announces Funding of Management-led $2,100,000 Above Market Private Placement at $3.00 Per Share
6:03am
8-K
tt2bwnn
9 Apr 21
Entry into a Material Definitive Agreement
9:06am
8-K
23p0w ji8n2kwld8se
15 Mar 21
Adial Announces Management-Led $2,100,000
9:24am
8-K
wimu9
26 Feb 21
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
9:51am
8-K
6gyzzpjzk0z9op
12 Feb 21
Departure of Directors or Certain Officers
4:45pm
8-K
bqp8kombga 8nuxvk
1 Feb 21
Adial Pharmaceuticals Closes Acquisition of Purnovate
5:27pm
8-K
t69 w11pv3f
17 Dec 20
Entry into a Material Definitive Agreement
5:09pm
8-K
fqqy4dmcg r2gd
16 Dec 20
Other Events
5:05pm
8-K
mf8ah01lmbtazr0h
10 Dec 20
Entry into a Material Definitive Agreement
9:45am
8-K
su5rbkc bkl
9 Dec 20
Departure of Directors or Certain Officers
9:41am
8-K
19b2p5dem7
24 Nov 20
Entry into a Material Definitive Agreement
5:00pm
8-K
b5o7moshs tn
3 Nov 20
Adial Pharmaceuticals Provides Update on its ONWARD™ Pivotal Phase 3 Trial of AD04 for Treatment of Alcohol Use Disorder
9:54am
8-K
v3kdlb3kd
21 Oct 20
Adial Pharmaceuticals Announces FDA Reactivation of its Investigational New Drug Application for AD04 in Alcohol Use Disorder
12:26pm
8-K
gau5ev
1 Oct 20
Other Events
9:00am
8-K
ypx4x ghm
30 Sep 20
Other Events
9:00am
8-K
hkgkfxz8beppgrdv
28 Sep 20
Adial Pharmaceuticals Files for Expedited Review of AD04 with the FDA
9:52am